Biodexa Pharmaceuticals (BDRX) Current Deferred Revenue (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Current Deferred Revenue of $748883.6 for Q4 2025, up 8.45% on a YoY basis from $690524.0 in Q4 2024, and up 8.45% sequentially from $690524.0 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Current Deferred Revenue (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 7 years of Current Deferred Revenue data on file, last reported at $748883.6 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue rose 8.45% year-over-year to $748883.6; the trailing twelve-month figure through Dec 2025 stood at $748883.6 (up 8.45% YoY), and the FY2025 full-year result was $742321.3, up 7.5% from the prior year.
- Current Deferred Revenue rose to $748883.6 in Q4 2025, from $690524.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $748883.6 in Q4 2025 to a low of -$231066.9 in Q4 2022.
- A 3-year average of $402780.2 and a median of $690524.0 in 2024 frame the typical range for Current Deferred Revenue.
- Peak annual rise in Current Deferred Revenue reached 8.45% in 2025, while the deepest fall reached 8.45% in 2025.
- Tracing BDRX's Current Deferred Revenue over 3 years: stood at -$231066.9 in 2022, then jumped by 398.84% to $690524.0 in 2024, then advanced by 8.45% to $748883.6 in 2025.
- Business Quant data shows BDRX's Current Deferred Revenue at $748883.6 in Q4 2025, $690524.0 in Q4 2024, and -$231066.9 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 748,883.57 |
| Dec 31, 2024 | 690,523.99 |
| Dec 31, 2022 | -231,066.88 |
| Dec 31, 2020 | -89,790.67 |
| Dec 31, 2015 | 2.09 Mn |
| Dec 31, 2014 | 248,751.29 |
| Dec 31, 2013 | 238,003.77 |